Taxation With Representation: Sullivan, Baker Botts, Kirkland

Law360 (August 30, 2019, 4:12 PM EDT) -- In this week’s Taxation With Representation, Amgen shells out $13.4 billion for a psoriasis drug, BP PLC sells its entire Alaska business for $5.6 billion and PDC Energy expands its Denver foothold with a $1.7 billion acquisition.

Amgen’s $13.4B Pharma Buy

Amgen on Aug. 26 said it will shell out $13.4 billion for Celgene’s psoriasis and psoriatic arthritis drug, a deal shaped by five law firms that is aimed at lessening competition concerns with Bristol-Myers Squibb’s Celgene takeover.

The deal will see Amgen, which is led by Sullivan & Cromwell LLP, buy the global rights to Otezla as Bristol-Myers Squibb Co.,...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS